Found: 10
Select item for more details and to access through your institution.
Retraction statement: Effects of flavocoxid, a dual inhibitor of COX and 5‐lipoxygenase enzymes, on benign prostatic hyperplasia.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 16, p. 2189, doi. 10.1111/bph.16153
- Publication type:
- Article
Targeting formyl peptide receptor 1 with anteiso‐C13‐surfactin for neutrophil‐dominant acute respiratory distress syndrome.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 16, p. 2120, doi. 10.1111/bph.16073
- By:
- Publication type:
- Article
Palbociclib blocks neutrophilic phosphatidylinositol 3‐kinase activity to alleviate psoriasiform dermatitis.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 16, p. 2172, doi. 10.1111/bph.16080
- By:
- Publication type:
- Article
Peroxisome proliferator‐activated receptor δ improves the features of atherosclerotic plaque vulnerability by regulating smooth muscle cell phenotypic switching.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 16, p. 2085, doi. 10.1111/bph.16074
- By:
- Publication type:
- Article
Airway delivery of Streptococcus salivarius is sufficient to induce experimental pulmonary hypertension in rats.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 16, p. 2102, doi. 10.1111/bph.16064
- By:
- Publication type:
- Article
Chlorogenic acid reduces inflammation by inhibiting the elevated expression of KAT2A to ameliorate lipopolysaccharide‐induced acute lung injury.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 16, p. 2156, doi. 10.1111/bph.16069
- By:
- Publication type:
- Article
RGS6 negatively regulates inhibitory G protein signaling in dopamine neurons and positively regulates binge‐like alcohol consumption in mice.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 16, p. 2140, doi. 10.1111/bph.16071
- By:
- Publication type:
- Article
Improved PIEZO1 agonism through 4‐benzoic acid modification of Yoda1.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 16, p. 2039, doi. 10.1111/bph.15996
- By:
- Publication type:
- Article
Veklury® (remdesivir) formulations inhibit initial membrane‐coupled events of SARS‐CoV‐2 infection due to their sulfobutylether‐β‐cyclodextrin content.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 16, p. 2064, doi. 10.1111/bph.16063
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Pharmacology, 2023, v. 180, n. 16, p. 2037, doi. 10.1111/bph.15884
- Publication type:
- Article